Pharmaterials are pleased to announce the expansion of their manufacturing, analytical and stability facilities. Due to the continued growth of the business and to meet our customers’ needs in the future, Pharmaterials is investing significantly to expand the GMP manufacturing operations at their Reading, UK site.The addition of new GMP manufacturing rooms to the existing facility will quadruple capacity and allow the company to support the IMP operations and meet client expectations, as well as expand in new areas. To complement the expansion of the manufacturing base a larger analytical laboratory is also being constructed. Part of the expansion plan is to expand inhalation development and a dedicated inhalation development laboratory will be added to cover future client needs. Provision is also being made to support future commercial and specials manufacturing operations as well as clinical trial labelling and distribution. The first part of the investment, a new suite of 4 walk in stability chambers is already in operation supporting client development programs and provides a standalone facility for stability storage and testing programs.
Manufacturing and Stability Expansion
« Back to News